Simplex Trading
NAGE

Simplex Trading’s Niagen Bioscience NAGE Stock Holding History

Simplex Trading’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91K Sell
600
-28,200
-98% -$114K ﹤0.01% 8646
2026
Q1 		$127K Sell
28,800
-7,800
-21% -$42.1K ﹤0.01% 4807
2025
Q4 		$233K Buy
36,600
+17,100
+88% +$119K ﹤0.01% 4071
2025
Q3 		$181K Buy
19,500
+6,900
+55% +$69.7K ﹤0.01% 5064
2025
Q2 		$181K Buy
12,600
+7,200
+133% +$71.1K ﹤0.01% 4621
2025
Q1 		$37K Sell
5,400
-9,600
-64% -$60.3K ﹤0.01% 6084
2024
Q4 		$79K Hold
15,000
– – ﹤0.01% 5408
2024
Q3 		$54K Sell
15,000
-8,100
-35% -$25.5K ﹤0.01% 5820
2024
Q2 		$63K Sell
23,100
-400
-2% -$1.34K ﹤0.01% 5850
2024
Q1 		$81K Buy
+23,500
New +$43.5K ﹤0.01% 5808
2023
Q3 		– Sell
-37,000
Closed -$58K – 10068
2023
Q2 		$58K Buy
37,000
+22,900
+162% +$34.2K ﹤0.01% 5704
2023
Q1 		$21K Sell
14,100
-1,000
-7% -$1.78K ﹤0.01% 6887
2022
Q4 		$25K Sell
15,100
-2,100
-12% -$3.33K ﹤0.01% 6670
2022
Q3 		$21K Sell
17,200
-1,900
-10% -$3.06K ﹤0.01% 7487
2022
Q2 		$31K Buy
19,100
+3,900
+26% +$7.63K ﹤0.01% 7125
2022
Q1 		$37K Buy
15,200
+13,000
+591% +$35.5K ﹤0.01% 7555
2021
Q4 		$8K Sell
2,200
-33,300
-94% -$180K ﹤0.01% 9242
2021
Q3 		$347K Hold
35,500
– – ﹤0.01% 4678
2021
Q2 		$350K Buy
35,500
+34,009
+2,281% +$297K ﹤0.01% 4719
2021
Q1 		$1.39M Buy
+1,491
New +$11.8K ﹤0.01% 2037
2018
Q2 		– Sell
-4
Closed -$1K – 7983
2018
Q1 		$1K Buy
+4
New +$21 ﹤0.01% 5833
2017
Q3 		– Sell
-20
Closed -$2K – 6796
2017
Q2 		$2K Buy
+20
New +$63 ﹤0.01% 5374

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Simplex Trading's NAGE Position: Q2 2026 in Review

Simplex Trading reduced its Niagen Bioscience (NAGE) stake by 80% in Q2 2026, selling an estimated $87K and leaving 5,247 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7267.

Simplex Trading first reported a position in NAGE in Q2 2016 and has held it in 23 quarters since. The position peaked at $227K in Q3 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Simplex Trading held 5,247 shares of Niagen Bioscience worth $16.7K as of Q2 2026.
  • Simplex Trading sold 21,430 Niagen Bioscience shares in Q2 2026, an estimated $87K.
  • Niagen Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7267 holding.
  • Simplex Trading first reported a position in Niagen Bioscience in Q2 2016 and has held it in 23 quarters since.
  • Simplex Trading's Niagen Bioscience position peaked at $227K in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.